Immunologic response to Hib tetanus toxoid conjugated vaccine coadministered with DTPa either mixed or in two separate injections in toddlers not primed with Hib vaccine
| Autor: | Paul Willems, Sirli Meriste, Irja Lutsar, Jeanne-Marie Jacquet |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Haemophilus Infections
Immunology complex mixtures medicine Tetanus Toxoid Humans Vaccines Combined General Pharmacology Toxicology and Pharmaceutics Adverse effect Diphtheria-Tetanus-Pertussis Vaccine Haemophilus Vaccines Vaccines Conjugate biology Tetanus business.industry Immunogenicity Toxoid Haemophilus influenzae type b medicine.disease Vaccination Hib vaccine Immunization Child Preschool biology.protein Antibody Safety business |
| Zdroj: | Human vaccines. 4(1) |
| ISSN: | 1554-8619 |
| Popis: | This open randomized study compared the immunogenicity and safety of a diphtheria-tetanus-acellular pertussis (DTPa) and H. influenzae polyribosylribitol phosphate conjugated to the tetanus toxoid (Hib-PRP-T) vaccine (mixed prior to administration) with separate injections of DTPa and Hib vaccines in toddlers aged two years. A total of 119 children (60 mixed; 59 separate administration), primed with DTPw, but not with Hib vaccine were enrolled. Prior to immunization only 10.3% of toddlers had anti-PRP antibody titres > or =1.0 microg/ml, compared with all children on Days 7 and 30. The anti-PRP and anti-tetanus antibody geometric mean concentrations were lower after the combined DTPa/Hib vaccine compared to separately administered vaccines (47.16 microg/ml vs 78.36 microg/ml and 24.95 IU/ml vs 40.63 IU/ml, respectively). One month after vaccination all children had anti-tetanus and anti-diphtheria antibody titres above the protective level of > or =0.1 IU/ml. The rates of recorded adverse events were similar and mostly mild or moderate in intensity whether the vaccines were combined as a single injection or given separately. We conclude that in 2-year old children, previously not immunized against Hib, a single dose of DTPa and Hib was safe and highly immunogenic irrespective of whether it was given as a combined vaccine or separate injections. Although the increase in anti-T and early (7-10 days after) anti-PRP concentrations was greater when the vaccine components were given separately than after combined administration, the DTPa/Hib combined vaccine would provide an effective method of delivering primary Hib vaccination in unprimed toddlers. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|